Clinical trial
A Relative Bioavailability Study of Ondansetron HCl 24 mg Tablets Under Fasting Conditions
NCT00946387 is registered in ClinicalTrials.gov with Sandoz as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Relative Bioavailability Study of Ondansetron HCl 24 mg Tablets Under Fasting Conditions
- Lead sponsor
- Sandoz
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- September 30, 2004
- Completion date
- September 30, 2004
- Enrollment
- 26 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.